Literature DB >> 3111527

Comparison of S100b protein with calmodulin: interactions with melittin and microtubule-associated tau proteins and inhibition of phosphorylation of tau proteins by protein kinase C.

J Baudier, D Mochly-Rosen, A Newton, S H Lee, D E Koshland, R D Cole.   

Abstract

To gauge similarities between S100b protein and calmodulin, interactions were observed between S100b and melittin and between S100b and tau, the microtubule-associated proteins. The interaction of melittin with S100b protein in the presence and absence of calcium was studied by fluorescence polarization, UV difference spectroscopy, and sulfhydryl derivatization. Whether calcium was present or not in the solution, melittin and S100b form a complex of molar ratios up to 2:1. Further binding of melittin occurred, but it resulted in precipitation of S100b, as is true of the corresponding case of melittin binding to calmodulin. In the absence of calcium, the interaction of melittin and S100b shielded the tryptophan (Trp) of the former protein and exposed cysteine-84 beta (Cys-84 beta) of the latter protein, leaving the tyrosine-16 beta (Tyr-16 beta) of S100b unaffected. Calcium addition to the complex partially restored the exposure of Trp of melittin and caused changes in the environment of Tyr-16 beta (unlike the environmental changes induced for Tyr-16 beta by calcium in the absence of melittin). The conformational changes induced in S100b by interaction with melittin increased its affinity for calcium and offset the inhibition of calcium binding otherwise observed in the presence of potassium ions. This corroborated the previous finding that S100b affinity for calcium greatly depends on the protein conformation. The phenomena described above are similar to the interactions of melittin with calmodulin and thus suggest that S100b and calmodulin have a common structural domain not only that binds melittin but also that may interact with common target proteins.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111527     DOI: 10.1021/bi00384a033

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease.

Authors:  W H Yu; P E Fraser
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

2.  Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein.

Authors:  J Baudier; C Delphin; D Grunwald; S Khochbin; J J Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

Review 3.  Calcium/calmodulin-dependent protein kinase II.

Authors:  R J Colbran; C M Schworer; Y Hashimoto; Y L Fong; D P Rich; M K Smith; T R Soderling
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

Review 4.  Calcium-dependent and -independent interactions of the S100 protein family.

Authors:  Liliana Santamaria-Kisiel; Anne C Rintala-Dempsey; Gary S Shaw
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

5.  Spectral studies of the Ca2+-dependent interaction of trifluoperazine with S100b.

Authors:  P L Pingerelli; H Mizukami; M J Mooney; A L Schlaepfer
Journal:  J Protein Chem       Date:  1989-04

Review 6.  The evolution of S100B inhibitors for the treatment of malignant melanoma.

Authors:  Kira G Hartman; Laura E McKnight; Melissa A Liriano; David J Weber
Journal:  Future Med Chem       Date:  2013-01       Impact factor: 3.808

7.  The S100B protein inhibits phosphorylation of GFAP and vimentin in a cytoskeletal fraction from immature rat hippocampus.

Authors:  D R Ziegler; C E Innocente; R B Leal; R Rodnight; C A Gonçalves
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

8.  Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins.

Authors:  T A Millward; C W Heizmann; B W Schäfer; B A Hemmings
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

9.  Immuno-detection of aluminium and aluminium induced conformational changes in calmodulin--implications in Alzheimer's disease.

Authors:  R Levi; T Wolf; G Fleminger; B Solomon
Journal:  Mol Cell Biochem       Date:  1998-12       Impact factor: 3.396

10.  Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice.

Authors:  J N Tsoporis; A Marks; H J Kahn; J W Butany; P P Liu; D O'Hanlon; T G Parker
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.